Literature DB >> 29175730

Formation and function of tissue-resident memory T cells during viral infection.

Haina Shin1.   

Abstract

Memory T cells are an important component of the adaptive immune response. Tissue-resident memory T cells (TRM) are a recently described subset of memory T cells that reside in peripheral tissues and are maintained independently of circulating subsets of memory T cells. Importantly, TRM are frequently found in barrier tissues that commonly serve as entry portals for pathogens such as viruses. Mounting evidence shows that TRM are superior to their circulating counterparts in conferring protective immunity against a wide range of viruses. In this review, we will discuss the role of TRM in controlling viral infection with a focus on CD8+ TRM, the factors that regulate differentiation and a potential role for TRM in future vaccine development.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29175730     DOI: 10.1016/j.coviro.2017.11.001

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.090


  7 in total

Review 1.  Tissue-resident lymphocytes: from adaptive to innate immunity.

Authors:  Haoyu Sun; Cheng Sun; Weihua Xiao; Rui Sun
Journal:  Cell Mol Immunol       Date:  2019-01-11       Impact factor: 11.530

2.  Targeting tissue-resident memory CD8+ T cells in the kidney is a potential therapeutic strategy to ameliorate podocyte injury and glomerulosclerosis.

Authors:  Liang Li; Wei Tang; Yan Zhang; Meng Jia; Limei Wang; Quanxin Li; Qingsheng Han; Xiuping Peng; Yusheng Xie; Jichao Wu; Ziying Wang; Junhui Zhen; Xiaojie Wang; Min Liu; Yu Sun; Chun Zhang; Fan Yi
Journal:  Mol Ther       Date:  2022-05-05       Impact factor: 12.910

3.  Gastric Subserous Vaccination With Helicobacter pylori Vaccine: An Attempt to Establish Tissue-Resident CD4+ Memory T Cells and Induce Prolonged Protection.

Authors:  Wei Liu; Zhiqin Zeng; Shuanghui Luo; Chupeng Hu; Ningyin Xu; An Huang; Lufeng Zheng; Eric J Sundberg; Tao Xi; Yingying Xing
Journal:  Front Immunol       Date:  2019-05-17       Impact factor: 7.561

Review 4.  Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic.

Authors:  Anne-Marie C Dingemans; Ross A Soo; Abdul Rahman Jazieh; Shawn J Rice; Young Tae Kim; Lynette L S Teo; Graham W Warren; Shu-Yuan Xiao; Egbert F Smit; Joachim G Aerts; Soon Ho Yoon; Giulia Veronesi; Francesco De Cobelli; Suresh S Ramalingam; Marina C Garassino; Murry W Wynes; Madhusmita Behera; John Haanen; Shun Lu; Solange Peters; Myung-Ju Ahn; Giorgio V Scagliotti; Alex A Adjei; Chandra P Belani
Journal:  J Thorac Oncol       Date:  2020-05-15       Impact factor: 15.609

5.  Skin and heart allograft rejection solely by long-lived alloreactive TRM cells in skin of severe combined immunodeficient mice.

Authors:  Qianchuan Tian; Zhaoqi Zhang; Liang Tan; Fan Yang; Yanan Xu; Yinan Guo; Dong Wei; Changhong Wu; Peng Cao; Jiawei Ji; Wei Wang; Xubiao Xie; Yong Zhao
Journal:  Sci Adv       Date:  2022-01-26       Impact factor: 14.136

6.  Targeting chronic COVID-19 lung injury; Tofacitinib can be used against tissue-resident memory T cells.

Authors:  Sepideh Zununi Vahed; Seyed Mahdi Hosseiniyan Khatibi; Elham Ahmadian; Mohammadreza Ardalan
Journal:  Biomed Pharmacother       Date:  2022-01-04       Impact factor: 6.529

7.  Perivascular Lymphocyte Clusters Induced by Gastric Subserous Layer Vaccination Mediate Optimal Immunity against Helicobacter through Facilitating Immune Cell Infiltration and Local Antibody Response.

Authors:  Chupeng Hu; Wei Liu; Ningyin Xu; An Huang; Zhiqin Zeng; Shuanghui Luo; Zhenxing Zhang; Menghui Fan; Feng Ye; Tao Xi; Yingying Xing
Journal:  J Immunol Res       Date:  2020-01-11       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.